Ubs Group Ag Talis Biomedical Corp Transaction History

Ubs Group Ag

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.48 - $0.64 $3,224 - $4,298	-6,717 Reduced 99.61%	26 $0
Q4 2022 Feb 08, 2023	BUY	$0.45 - $11.67 $3,022 - $78,387	6,717 Added 25834.62%	6,743 $3,000
Q3 2022 Nov 10, 2022	BUY	$0.7 - $10.79 $4 - $64	6 Added 30.0%	26 $0
Q2 2022 Aug 10, 2022	SELL	$0.81 - $1.44 $2,207 - $3,924	-2,725 Reduced 99.27%	20 $0
Q1 2022 May 16, 2022	SELL	$1.3 - $4.19 $6,154 - $19,835	-4,734 Reduced 63.3%	2,745 $4,000
Q4 2021 Feb 14, 2022	BUY	$3.81 - $6.17 $28,494 - $46,145	7,479 New	7,479 $30,000
Q3 2021 Nov 15, 2021	SELL	$6.02 - $12.46 $3,256 - $6,740	-541 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$9.62 - $14.56 $25,685 - $38,875	-2,670 Reduced 83.15%	541 $6,000
Q1 2021 May 12, 2021	BUY	$11.2 - $27.8 $35,963 - $89,265	3,211 New	3,211 $41,000

Ticker TLIS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 26,619,200
Market Cap $45.8M
Description
Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. ...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.